Skip to content
2000
Volume 7, Issue 1
  • ISSN: 2666-7967
  • E-ISSN: 2666-7975

Abstract

Introduction

This umbrella review offers a comprehensive analysis of the association between age and other risk factors in the incidence and severity of COVID-19.

Methods

This umbrella review aims to compare age with other risk factors of COVID-19 infection. Literature featuring systematic reviews and the English language in electronic databases of PubMed, Embase, Scopus, and Web of Science was considered for this purpose. Appropriate articles were selected following two separate steps, and after meeting the inclusion/exclusion criteria, they went through data extraction. This umbrella review coheres with the PRISMA checklist and the AMSTAR-2 tool specified for quality assessment.

Results

A total of 55 articles met the inclusion criteria. For risk factors associated with COVID-19 severity, the most relevant were age and underlying comorbidities, each identified in 45 cases. Obesity was noted in 12 cases, making it the least prevalent risk factor in the studies. Other factors included sex, smoking, and conditions during hospitalization. For clinical outcomes, in addition to issues such as discharge, ICU, death, ., other issues such as renal and cardiovascular disorders were observed.

Conclusion

The collective evidence presented in this review underscores various risk factors associated with severe COVID-19 outcomes, which can be used to update clinical management guidelines and assist in determining patients’ prognoses.

© 2026 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/covid/10.2174/0126667975321293240913082528
2024-09-24
2026-01-02

  • From This Site

    /content/journals/covid/10.2174/0126667975321293240913082528
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. BohnM.K. HallA. SepiashviliL. JungB. SteeleS. AdeliK. Pathophysiology of COVID-19: Mechanisms underlying disease severity and progression.Physiology (Bethesda)202035528830110.1152/physiol.00019.202032783610
     [Google Scholar]
  2. WiersingaW.J. RhodesA. ChengA.C. PeacockS.J. PrescottH.C. Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): A review.JAMA2020324878279310.1001/jama.2020.1283932648899
     [Google Scholar]
  3. Coronavirus Disease 2019 (COVID-19) Treatment Guidelines. National Institutes of Health.Available at: https://www.covid19treatmentguidelines.nih.gov/
    [Google Scholar]
  4. VegivintiC.T.R. EvansonK.W. LyonsH. Efficacy of antiviral therapies for COVID-19: A systematic review of randomized controlled trials.BMC Infect. Dis.202222110710.1186/s12879‑022‑07068‑035100985
     [Google Scholar]
  5. KumarS. SinghR. KumariN. Current understanding of the influence of environmental factors on SARS-CoV-2 transmission, persistence, and infectivity.Environ. Sci. Pollut. Res. Int.20212866267628810.1007/s11356‑020‑12165‑133387315
     [Google Scholar]
  6. HoF.K. Celis-MoralesC.A. GrayS.R. Modifiable and non-modifiable risk factors for COVID-19, and comparison to risk factors for influenza and pneumonia: Results from a UK Biobank prospective cohort study.BMJ Open20201011e04040210.1136/bmjopen‑2020‑04040233444201
     [Google Scholar]
  7. WilliamsonE.J. WalkerA.J. BhaskaranK. Factors associated with COVID-19-related death using OpenSAFELY.Nature2020584782143043610.1038/s41586‑020‑2521‑432640463
     [Google Scholar]
  8. ZhouF. YuT. DuR. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study.Lancet2020395102291054106210.1016/S0140‑6736(20)30566‑332171076
     [Google Scholar]
  9. FangX. LiS. YuH. Epidemiological, comorbidity factors with severity and prognosis of COVID-19: A systematic review and meta-analysis.Aging (Albany NY)20201213124931250310.18632/aging.10357932658868
     [Google Scholar]
  10. PijlsB.G. JolaniS. AtherleyA. Demographic risk factors for COVID-19 infection, severity, ICU admission and death: A meta-analysis of 59 studies.BMJ Open2021111e04464010.1136/bmjopen‑2020‑04464033431495
     [Google Scholar]
  11. O’DriscollM. Ribeiro Dos SantosG. WangL. Age-specific mortality and immunity patterns of SARS-CoV-2.Nature2021590784414014510.1038/s41586‑020‑2918‑033137809
     [Google Scholar]
  12. BoothA. ReedA.B. PonzoS. Population risk factors for severe disease and mortality in COVID-19: A global systematic review and meta-analysis.PLoS One2021163e024746110.1371/journal.pone.024746133661992
     [Google Scholar]
  13. DuP. LiD. WangA. ShenS. MaZ. LiX. A systematic review and meta-analysis of risk factors associated with severity and death in COVID-19 patients.Can. J. Infect. Dis. Med. Microbiol.20212021111210.1155/2021/666093033936349
     [Google Scholar]
  14. EbingerJ.E. AchamallahN. JiH. Pre-existing traits associated with COVID-19 illness severity.PLoS One2020157e023624010.1371/journal.pone.023624032702044
     [Google Scholar]
  15. BaeS. KimS.R. KimM.N. ShimW.J. ParkS.M. Impact of cardiovascular disease and risk factors on fatal outcomes in patients with COVID-19 according to age: A systematic review and meta-analysis.Heart2021107537338010.1136/heartjnl‑2020‑31790133334865
     [Google Scholar]
  16. GeE. LiY. WuS. CandidoE. WeiX. Association of pre-existing comorbidities with mortality and disease severity among 167,500 individuals with COVID-19 in Canada: A population-based cohort study.PLoS One20211610e025815410.1371/journal.pone.025815434610047
     [Google Scholar]
  17. GutierrezJ.P. BertozziS.M. Non-communicable diseases and inequalities increase risk of death among COVID-19 patients in Mexico.PLoS One20201510e024039410.1371/journal.pone.024039433031467
     [Google Scholar]
  18. HanS. ZhuangQ. ChiangJ. Impact of cancer diagnoses on the outcomes of patients with COVID-19: A systematic review and meta-analysis.BMJ Open2022122e04466110.1136/bmjopen‑2020‑04466135131810
     [Google Scholar]
  19. SohrabiM.R. AminR. MaherA. Sociodemographic determinants and clinical risk factors associated with COVID-19 severity: A cross-sectional analysis of over 200,000 patients in Tehran, Iran.BMC Infect. Dis.202121147410.1186/s12879‑021‑06179‑434034649
     [Google Scholar]
  20. COVID-19 Host Genetics Initiative. Mapping the human genetic architecture of COVID-19.Nature20216007889472477
     [Google Scholar]
  21. SieurinJ. BrandénG. MagnussonC. HergensM.P. KosidouK. A population-based cohort study of sex and risk of severe outcomes in covid-19.Eur. J. Epidemiol.202237111159116910.1007/s10654‑022‑00919‑936301399
     [Google Scholar]
  22. SallisR. YoungD.R. TartofS.Y. Physical inactivity is associated with a higher risk for severe COVID-19 outcomes: A study in 48 440 adult patients.Br. J. Sports Med.202155191099110510.1136/bjsports‑2021‑10408033849909
     [Google Scholar]
  23. WendtF.R. De LilloA. PathakG.A. De AngelisF. PolimantiR. Host genetic liability for severe COVID-19 associates with alcohol drinking behavior and diabetic outcomes in participants of European descent.Front. Genet.20211276524710.3389/fgene.2021.76524734966408
     [Google Scholar]
  24. CliftA.K. von EndeA. TanP.S. Smoking and COVID-19 outcomes: An observational and Mendelian randomisation study using the UK Biobank cohort.Thorax2022771657310.1136/thoraxjnl‑2021‑21708034580193
     [Google Scholar]
  25. ZhaoX. LiY. GeY. Evaluation of nutrition risk and its association with mortality risk in severely and critically ill COVID‐19 patients.JPEN J. Parenter. Enteral Nutr.2021451324210.1002/jpen.195332613660
     [Google Scholar]
  26. Abu-RaddadL.J. ChemaitellyH. AyoubH.H. Severity, criticality, and fatality of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Beta variant.Clin. Infect. Dis.2022751e1188e119110.1093/cid/ciab90934657152
     [Google Scholar]
  27. Van DammeW. DahakeR. van de PasR. VanhamG. AssefaY. COVID-19: Does the infectious inoculum dose-response relationship contribute to understanding heterogeneity in disease severity and transmission dynamics?Med. Hypotheses202114611043110.1016/j.mehy.2020.11043133288314
     [Google Scholar]
  28. WachtlerB. MichalskiN. NowossadeckE. DierckeM. WahrendorfM. Santos-HövenerC. Socioeconomic inequalities and COVID-19 – A review of the current international literature. Additional material: Overview of the included publications.J. Health Monit.20205Suppl. 7e1e12
     [Google Scholar]
  29. ManivannanJ. SundaresanL. Systems level insights into the impact of airborne exposure on SARS-CoV-2 pathogenesis and COVID-19 outcome – A multi-omics big data study.Gene Rep.20212510131210.1016/j.genrep.2021.10131234401607
     [Google Scholar]
  30. FaiyazuddinM. SophiaA. AshiqueS. Virulence traits and novel drug delivery strategies for mucormycosis post-COVID-19: A comprehensive review.Front. Immunol.202314126450210.3389/fimmu.2023.126450237818370
     [Google Scholar]
  31. AkbariA. FathabadiA. RazmiM. Characteristics, risk factors, and outcomes associated with readmission in COVID-19 patients: A systematic review and meta-analysis.Am. J. Emerg. Med.20225216617310.1016/j.ajem.2021.12.01234923196
     [Google Scholar]
  32. ApostolopoulouA. GarrigosE.Z. VijayvargiyaP. LernerA.H. FarmakiotisD. Invasive pulmonary aspergillosis in patients with SARS-CoV-2 infection: A systematic review of the literature.Diagnostics (Basel)2020101080710.3390/diagnostics1010080733050499
     [Google Scholar]
  33. BaralP.K. AzizM.A. IslamM.S. Comparative risk assessment of COVID‐19 associated mucormycosis and aspergillosis: A systematic review.Health Sci. Rep.202255e78910.1002/hsr2.78936000078
     [Google Scholar]
  34. BentivegnaM. HulmeC. EbellM.H. Primary care relevant risk factors for adverse outcomes in patients with COVID-19 infection: A systematic review.J. Am. Board Fam. Med.202134Suppl.S113S12610.3122/jabfm.2021.S1.20042933622826
     [Google Scholar]
  35. BepoukaB. MayasiN. MandinaM. Risk factors for mortality in COVID-19 patients in sub-Saharan Africa: A systematic review and meta-analysis.PLoS One20221710e027600810.1371/journal.pone.027600836251715
     [Google Scholar]
  36. BepoukaB. OdioO. MayasiN. Prevalence and outcomes of COVID −19 patients with happy hypoxia: A systematic review.Infect. Drug Resist.2022155619562810.2147/IDR.S37806036172621
     [Google Scholar]
  37. MartimbiancoC.A.L. PachecoR.L. BagattiniÂ.M. RieraR. Frequency, signs and symptoms, and criteria adopted for long COVID‐19: A systematic review.Int. J. Clin. Pract.20217510e1435710.1111/ijcp.1435733977626
     [Google Scholar]
  38. CaiX. WuG. ZhangJ. YangL. Risk factors for acute kidney injury in adult patients with COVID-19: A systematic review and meta-analysis.Front. Med. (Lausanne)2021871947210.3389/fmed.2021.71947234938742
     [Google Scholar]
  39. DegaregeA. NaveedZ. KabayundoJ. Brett-MajorD. Heterogeneity and risk of bias in studies examining risk factors for severe illness and death in COVID-19: A systematic review and meta-analysis.Pathogens202211556310.3390/pathogens1105056335631084
     [Google Scholar]
  40. Del SoleF. FarcomeniA. LoffredoL. Features of severe COVID‐19: A systematic review and meta‐analysis.Eur. J. Clin. Invest.20205010e1337810.1111/eci.1337832860457
     [Google Scholar]
  41. DessieZ.G. ZewotirT. Mortality-related risk factors of COVID-19: A systematic review and meta-analysis of 42 studies and 423,117 patients.BMC Infect. Dis.202121185510.1186/s12879‑021‑06536‑334418980
     [Google Scholar]
  42. DuY. ZhouN. ZhaW. LvY. Hypertension is a clinically important risk factor for critical illness and mortality in COVID-19: A meta-analysis.Nutr. Metab. Cardiovasc. Dis.202131374575510.1016/j.numecd.2020.12.00933549450
     [Google Scholar]
  43. VillalobosF.N.V. OttJ.J. Klett-TammenC.J. Effect modification of the association between comorbidities and severe course of COVID-19 disease by age of study participants: A systematic review and meta-analysis.Syst. Rev.202110119410.1186/s13643‑021‑01732‑334193261
     [Google Scholar]
  44. FlookM. JacksonC. VasileiouE. Informing the public health response to COVID-19: A systematic review of risk factors for disease, severity, and mortality.BMC Infect. Dis.202121134210.1186/s12879‑021‑05992‑133845766
     [Google Scholar]
  45. IzcovichA. RagusaM.A. TortosaF. Prognostic factors for severity and mortality in patients infected with COVID-19: A systematic review.PLoS One20201511e024195510.1371/journal.pone.024195533201896
     [Google Scholar]
  46. KellerK.G. ReangsingC. SchneiderJ.K. Clinical presentation and outcomes of hospitalized adults with COVID‐19: A systematic review.J. Adv. Nurs.202076123235325710.1111/jan.1455832881050
     [Google Scholar]
  47. KimH.J. HwangH. HongH. YimJ.J. LeeJ. A systematic review and meta-analysis of regional risk factors for critical outcomes of COVID-19 during early phase of the pandemic.Sci. Rep.2021111978410.1038/s41598‑021‑89182‑833963250
     [Google Scholar]
  48. KowsarR. RahimiA.M. SrokaM. Risk of mortality in COVID-19 patients: A meta- and network analysis.Sci. Rep.2023131213810.1038/s41598‑023‑29364‑836747045
     [Google Scholar]
  49. LiJ. HuangD.Q. ZouB. Epidemiology of COVID‐19: A systematic review and meta‐analysis of clinical characteristics, risk factors, and outcomes.J. Med. Virol.20219331449145810.1002/jmv.2642432790106
     [Google Scholar]
  50. LiY. AshcroftT. ChungA. Risk factors for poor outcomes in hospitalised COVID-19 patients: A systematic review and meta-analysis.J. Glob. Health2021111000110.7189/jogh.11.1000133767855
     [Google Scholar]
  51. LooW.K. HasikinK. SuhaimiA. Systematic review on COVID-19 readmission and risk factors: future of machine learning in COVID-19 readmission studies.Front. Public Health20221089825410.3389/fpubh.2022.89825435677770
     [Google Scholar]
  52. LuL. ZhongW. BianZ. A comparison of mortality-related risk factors of COVID-19, SARS, and MERS: A systematic review and meta-analysis.J. Infect.2020814e18e2510.1016/j.jinf.2020.07.00232634459
     [Google Scholar]
  53. MartonoM. FatmawatiF. MulyantiS. Risk factors associated with the severity of COVID-19.Malays. J. Med. Sci.2023303849210.21315/mjms2023.30.3.737425387
     [Google Scholar]
  54. MehriA. GhorbaniS.S. Farhadi-BabadiK. Risk factors associated with severity and death from COVID-19 in Iran: A systematic review and meta-analysis study.J. Intensive Care Med.202338982583710.1177/0885066623116634436976873
     [Google Scholar]
  55. MesasA.E. Cavero-RedondoI. Álvarez-BuenoC. Predictors of in-hospital COVID-19 mortality: A comprehensive systematic review and meta-analysis exploring differences by age, sex and health conditions.PLoS One20201511e024174210.1371/journal.pone.024174233141836
     [Google Scholar]
  56. NotarteK.I. de OliveiraM.H.S. PeligroP.J. Age, sex and previous comorbidities as risk factors not associated with SARS-CoV-2 infection for long COVID-19: A systematic review and meta-analysis.J. Clin. Med.20221124731410.3390/jcm1124731436555931
     [Google Scholar]
  57. OuM. ZhuJ. JiP. Risk factors of severe cases with COVID-19: A meta-analysis.Epidemiol. Infect.2020148e17510.1017/S095026882000179X32782035
     [Google Scholar]
  58. ParohanM. YaghoubiS. SerajiA. JavanbakhtM.H. SarrafP. DjalaliM. Risk factors for mortality in patients with Coronavirus disease 2019 (COVID-19) infection: A systematic review and meta-analysis of observational studies.Aging Male20202351416142410.1080/13685538.2020.177474832508193
     [Google Scholar]
  59. PatelU. MalikP. UsmanM.S. Age-adjusted risk factors associated with mortality and mechanical ventilation utilization amongst COVID-19 hospitalizations—a systematic review and meta-analysis.SN Compr. Clin. Med.20202101740174910.1007/s42399‑020‑00476‑w32904541
     [Google Scholar]
  60. PranataR. HuangI. LimM.A. WahjoepramonoE.J. JulyJ. Impact of cerebrovascular and cardiovascular diseases on mortality and severity of COVID-19–systematic review, meta-analysis, and meta-regression.J. Stroke Cerebrovasc. Dis.202029810494910.1016/j.jstrokecerebrovasdis.2020.104949
     [Google Scholar]
  61. Romero StarkeK. Petereit-HaackG. SchubertM. The age-related risk of severe outcomes due to COVID-19 infection: A rapid review, meta-analysis, and meta-regression.Int. J. Environ. Res. Public Health20201716597410.3390/ijerph1716597432824596
     [Google Scholar]
  62. SabatinoJ. De RosaS. Di SalvoG. IndolfiC. Impact of cardiovascular risk profile on COVID-19 outcome. A meta-analysis.PLoS One2020158e023713110.1371/journal.pone.023713132797054
     [Google Scholar]
  63. SeiduS. GilliesC. ZaccardiF. The impact of obesity on severe disease and mortality in people with SARS‐CoV‐2: A systematic review and meta‐analysis.Endocrinol. Diabetes Metab.202141e0017610.1002/edm2.17632904932
     [Google Scholar]
  64. ShiC. WangL. YeJ. Predictors of mortality in patients with coronavirus disease 2019: A systematic review and meta-analysis.BMC Infect. Dis.202121166310.1186/s12879‑021‑06369‑034238232
     [Google Scholar]
  65. SilverioA. Di MaioM. CitroR. Cardiovascular risk factors and mortality in hospitalized patients with COVID-19: systematic review and meta-analysis of 45 studies and 18,300 patients.BMC Cardiovasc. Disord.20212112310.1186/s12872‑020‑01816‑333413093
     [Google Scholar]
  66. SinghA. SinghY. PangasaN. KhannaP. TrikhaA. Risk factors, clinical characteristics, and outcome of air leak syndrome in COVID-19: A systematic review.Indian J. Crit. Care Med.202125121434144510.5005/jp‑journals‑10071‑2405335027806
     [Google Scholar]
  67. SoerotoA.Y. SoetedjoN.N. PurwigaA. Effect of increased BMI and obesity on the outcome of COVID-19 adult patients: A systematic review and meta-analysis.Diabetes Metab. Syndr.20201461897190410.1016/j.dsx.2020.09.02933007661
     [Google Scholar]
  68. TaylorE.H. MarsonE.J. ElhadiM. Factors associated with mortality in patients with COVID‐19 admitted to intensive care: A systematic review and meta‐analysis.Anaesthesia20217691224123210.1111/anae.1553234189735
     [Google Scholar]
  69. TsaiY.T. KuH.C. MaithreepalaS.D. Higher risk of acute respiratory distress syndrome and risk factors among patients with COVID-19: A systematic review, meta-analysis and meta-regression.Int. J. Environ. Res. Public Health202219221512510.3390/ijerph19221512536429842
     [Google Scholar]
  70. WangB. LuoQ. ZhangW. YuS. ChengX. WangL. The involvement of chronic kidney disease and acute kidney injury in disease severity and mortality in patients with COVID-19: A meta-analysis.SwitzerlandS. Karger AG Basel20211730
     [Google Scholar]
  71. WangY. NanL. HuM. Significant association between anemia and higher risk for COVID-19 mortality: A meta-analysis of adjusted effect estimates.Am. J. Emerg. Med.20225828128510.1016/j.ajem.2022.06.03035753290
     [Google Scholar]
  72. WuX. LiuL. JiaoJ. YangL. ZhuB. LiX. Characterisation of clinical, laboratory and imaging factors related to mild vs. severe COVID-19 infection: A systematic review and meta-analysis.Ann. Med.202052733434410.1080/07853890.2020.180206132755287
     [Google Scholar]
  73. WuY. LiH. ZhangZ. Risk factors for mortality of coronavirus disease 2019 (COVID-19) patients during the early outbreak of COVID-19: A systematic review and meta-analysis.Ann. Palliat. Med.20211055069508310.21037/apm‑20‑255733894729
     [Google Scholar]
  74. XiangG. XieL. ChenZ. Clinical risk factors for mortality of hospitalized patients with COVID-19: Systematic review and meta-analysis.Ann. Palliat. Med.20211032723273510.21037/apm‑20‑127833549005
     [Google Scholar]
  75. XuJ. XiaoW. LiangX. A meta-analysis on the risk factors adjusted association between cardiovascular disease and COVID-19 severity.BMC Public Health2021211153310.1186/s12889‑021‑11051‑w34380456
     [Google Scholar]
  76. ZhangJ. PangQ. ZhouT. Risk factors for acute kidney injury in COVID-19 patients: An updated systematic review and meta-analysis.Ren. Fail.2023451217080910.1080/0886022X.2023.217080937021610
     [Google Scholar]
  77. ZhangJ. WuJ. SunX. Association of hypertension with the severity and fatality of SARS-CoV-2 infection: A meta-analysis.Epidemiol. Infect.2020148e10610.1017/S095026882000117X32460927
     [Google Scholar]
  78. ZhangY.J. SunX.F. XieB. FengW.J. HanS.L. Exploration of severe COVID‐19 associated risk factor in China: Meta‐analysis of current evidence.New York, United StatesWiley Online Library2021e14900
     [Google Scholar]
  79. ZhaoJ. LiX. HuangW. ZhengJ. Potential risk factors for case fatality rate of novel coronavirus (COVID-19) in China: A pooled analysis of individual patient data.Am. J. Emerg. Med.202038112374238010.1016/j.ajem.2020.08.03933131974
     [Google Scholar]
  80. ZhengZ. PengF. XuB. Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis.J. Infect.2020812e16e2510.1016/j.jinf.2020.04.02132335169
     [Google Scholar]
  81. GaoY. DingM. DongX. Risk factors for severe and critically ill COVID‐19 patients: A review.Allergy202176242845510.1111/all.1465733185910
     [Google Scholar]
  82. HoK.S. NarasimhanB. SheehanJ. WuL. FungJ.Y. Controversy over smoking in COVID‐19—A real world experience in New York city.J. Med. Virol.20219374537454310.1002/jmv.2673833325049
     [Google Scholar]
  83. SimonsD. ShahabL. BrownJ. PerskiO. The association of smoking status with SARS‐CoV‐2 infection, hospitalization and mortality from COVID‐19: A living rapid evidence review with Bayesian meta‐analyses (version 7).Addiction202111661319136810.1111/add.1527633007104
     [Google Scholar]
  84. HuJ. WangY. The clinical characteristics and risk factors of severe COVID-19.SwitzerlandS. Karger AG Basel2021255266
     [Google Scholar]
  85. OrtizA. CozzolinoM. FliserD. Chronic kidney disease is a key risk factor for severe COVID-19: A call to action by the ERA-EDTA.Nephrol. Dial. Transplant.2021361879410.1093/ndt/gfaa31433340043
     [Google Scholar]
  86. O’GallagherK. ShekA. BeanD.M. Pre-existing cardiovascular disease rather than cardiovascular risk factors drives mortality in COVID-19.BMC Cardiovasc. Disord.202121132710.1186/s12872‑021‑02137‑934217220
     [Google Scholar]
  87. WeiY.Y. WangR.R. ZhangD.W. Risk factors for severe COVID-19: Evidence from 167 hospitalized patients in Anhui, China.J. Infect.2020811e89e9210.1016/j.jinf.2020.04.01032305487
     [Google Scholar]
  88. AshiqueS. GuptaK. GuptaG. Vitamin D—A prominent immunomodulator to prevent COVID ‐19 infection.Int. J. Rheum. Dis.2023261133010.1111/1756‑185X.1447736308699
     [Google Scholar]
  89. AshiqueS MishraN GargA A critical review on the longterm COVID-19 impacts on patients with diabetes.Am J Med2024S0002-934324001330013510.1016/j.amjmed.2024.02.02938485111
     [Google Scholar]
  90. PaudelK.R. PatelV. VishwasS. Nutraceuticals and COVID‐19: A mechanistic approach toward attenuating the disease complications.J. Food Biochem.20224612e1444510.1111/jfbc.1444536239436
     [Google Scholar]
/content/journals/covid/10.2174/0126667975321293240913082528
Loading
Risk Factors of Age VS Other Comorbidities in Severe COVID-19: An Umbrella Review
Coronaviruses 7, e26667975321293 (2026); https://doi.org/10.2174/0126667975321293240913082528
/content/journals/covid/10.2174/0126667975321293240913082528
/content/journals/covid/10.2174/0126667975321293240913082528
Loading

Data & Media loading...

Supplements

Supplementary material and PRISMA checklist are available on the publisher's website along with the published article.

file format download Download

  • Article Type:     Review Article
Keyword(s): Comorbidities; COVID-19; electronic databases; mortality; respiratory syndrome; risk factors

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test